Pivot Pharmaceuticals Inc
Formulated Using Pivot's Thrudermic™ Transdermal Nanotechnology VANCOUVER, Feb. 15, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE:PVOT / OTCQB:PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that the Company has completed the development of a controlled-release transdermal patch ... [Read]